Jean Ann, Rezdiffra patient, with family
Jean Ann, Rezdiffra patient, with family

Savings & Support

You’ve got our support.

Savings, comprehensive support, and prescription delivery are just some of the ways we’re here to help you.

Copay card

SAVINGS

Committed to helping patients find affordable access to Rezdiffra.

Eligible commercially insured patients may pay as little as $0 a month* with the Rezdiffra Copay Savings Card.

*Eligibility rules apply. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. For program terms, conditions, and eligibility criteria, visit copay.www.rezdiffra.com.

Document with shield icon

Support for those on Medicare Part D.

In January 2025, the Inflation Reduction Act (IRA) introduced updates to Medicare Part D that may help you manage your prescription drug costs.

Madrigal Patient Support logo

Have questions? Give us a call: 1-877-219-7770

Monday–Friday 8 AM–8 PM ET

PATIENT SUPPORT

Let us help you navigate your treatment with confidence.

At Madrigal Patient Support, we’re dedicated to offering comprehensive treatment support, including:

check circle icon

Identifying financial assistance options

check circle icon

Understanding costs and coverage

check circle icon

Support getting started and throughout treatment

check circle icon

Education and tips from Nurse Navigators

Rezdiffra Delivery

Rezdiffra is delivered right to you.

Your Rezdiffra prescription will be delivered directly to your doorstep from a specialty pharmacy. A specialty pharmacy stocks medications and treatments that are not typically found at your local retail pharmacy.

The process is simple and managed by Madrigal Patient Support or the specialty pharmacy.

Here’s how it works:

Prescription in mail envelope icon

Step 1

Your prescription is sent to a specialty pharmacy.

Prescription check box icon

Step 2

Medicine costs, coverage, and financial assistance options will be reviewed with you and confirmed.

Delivery truck icon

Step 3

You’ll get a call when your medicine is ready for delivery.

Cellphone icon

Step 4

When it’s time for a refill, you’ll get another call.

Raquel Rezdiffra Real Voices Ambassador

Mentor Program

Talk to a patient who’s taking Rezdiffra.

The Rezdiffra Real Voices™ Mentor Program is a great way to ask questions about:

  • Living with MASH with liver scarring
  • Being your own advocate and working with your healthcare team
  • Working with Madrigal Patient Support services
  • Finding support and resources

Call to register.

Computer icon

Managing MASH or fatty liver disease can be hard. Attend a free webinar for support and information.

Jean Ann Rezdiffra Real Voices Ambassador
Jean Ann Rezdiffra Real Voices Ambassador Animation

Rezdiffra is making a difference for Jean Ann.

Ask your liver specialist if Rezdiffra is right for you.

Patient stories reflect personal experience with Rezdiffra at the time of publication. Individual results may vary. Patient Ambassadors are sponsored by Madrigal Pharmaceuticals.

Important Safety Information and Indication

Expand Collapse

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.

Important Safety Information and Indication

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.